Gabriele Gallo Afflitto

TL;DR: An overview of the approved and in-development biologics targeting this axis is offered, emphasising how the availability of the “target” in the diseased tissues could provide a plausible explanation for the heterogeneous clinical efficacy of these drugs, thus opening future perspective of personalised therapies.

TL;DR: A systematic review of articles referenced in PubMed, Cochrane Library, Web of Science and Chinese Clinical Trial Register from December 20, 2019 to April 6, 2020, providing information on the presence of SARS-CoV-2 in cornea, conjunctiva, lacrimal sac, and tears found 11 articles met the inclusion criteria for analysis and were included in the study.

TL;DR: n-3 PUFAs supplementation could represent a promising therapeutic option to better control many features of RA and may represent an interesting perspective in future research as much in prevention as in treating RA.

TL;DR: The aim of this review is to provide the most current information regarding EDOF IOLs in terms of power calculating formulas, refractive outcomes, incidence of photic phenomena, and patient satisfaction.

TL;DR: In this article, the authors investigated the impact of Coronavirus Disease-2019 lockdown on the Italian Eye Bank organization and found that a statistically significant reduction in the number of donor corneas retrieved in 2020 was found as compared to the same period in 2019 and in 2018, respectively.